Herantis Pharma Oyj: Manager’s Transactions – Pekka Simula

Herantis Pharma Plc
Company release 18 Jun 2020 at 10:00 am

Herantis Pharma Plc
Company release 18 June 2020 at 10:00 AM Eastern European Summer Time

Herantis Pharma Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Pekka Simula

Position: Chief Executive Officer

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20200617140726_5

____________________________________________

Transaction date: 2020-06-18

Venue not applicable

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: EXERCISE OF A STOCK OPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 11,200 Unit price: .00005 EUR

(2): Volume: 16,000 Unit price: 2.92 EUR

Aggregated transactions

(2): Volume: 27,200 Volume weighted average price: 1.71767 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400

Distribution:

Main media
www.herantis.com